Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
E-pub ahead of print

Year-to-year variation in attack rates could result in underpowered respiratory syncytial virus vaccine efficacy trials

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Instruments assessing risk of bias of randomized trials frequently included items that are not addressing risk of bias issues

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Systematic Reviews are Rarely Used to Inform Study Design - a Systematic Review and Meta-analysis

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  3. Why clinical context and relevant protocols matter: response to Impellizzeri et al

    Publikation: Bidrag til tidsskriftLetterForskningpeer review

  • Marie-Noëlle Billard
  • Joanne Wildenbeest
  • Louis J Bont
  • Harish Nair
  • John P McCracken
  • Katrien Oude Rengerink
  • RESCEU Investigators
  • Thea Kølsen Fischer (Medlem af forfattergruppering)
Vis graf over relationer

OBJECTIVES: Year-to-year variation in respiratory viruses may result in lower attack rates than expected. We aimed to illustrate the impact of year-to-year variation in attack rates on the likelihood of demonstrating vaccine efficacy (VE).

STUDY DESIGN AND SETTING: We considered an individually randomized maternal vaccine trial against respiratory syncytial virus (RSV)-associated hospitalizations. For 10 RSV-associated hospitalizations per 1,000 infants, sample size to have 80% power for true VE of 50% and 70% was 9,846 and 4,424 participants. We reported power to show VE for varying attack rates, selected to reflect realistic year-to-year variation using observational studies. Eight scenarios including varying number of countries and seasons were developed to assess the influence of these trial parameters.

RESULTS: Including up to three seasons decreased the width of the interquartile range for power. Including more seasons concentrated statistical power closer to 80%. Least powered trials had higher statistical power with more seasons. In all scenarios, at least half of the trials had <80% power. For three-season trials, increasing the sample size by 10% reduced the percentage of underpowered trials to less than one-quarter of trials.

CONCLUSION: Year-to-year variation in RSV attack rates should be accounted for during trial design. Mitigation strategies include recruiting over more seasons, or adaptive trial designs.

TidsskriftJournal of Clinical Epidemiology
Sider (fra-til)11-20
Antal sider10
StatusE-pub ahead of print - 23 feb. 2022
Eksternt udgivetJa

Bibliografisk note

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

ID: 76482970